	Automating cost-effectiveness models with agentic artificial intelligence: Case study and implications for value assessment. J Manag Care Spec Pharm Mudumba R, Modi AB, Mayo K. PMID: 42640119 [PubMed - indexed for MEDLINE]
	Medicaid Expansion and Overall Mortality in Lung, Breast, and Colorectal Cancer: A Difference-in-Differences Study. Am Surg Akinyemi O, Heath JB, Oyebanji O, Fasokun M, Akinwumi B, Nnorom S, Ogunyankin F, Hughes K, Cornwell E 3rd, Levy G. PMID: 42640027 [PubMed - as supplied by publisher]
	Smoker's Lungs: Quo Vadis? Exploring the Shared and Individual Smoking-Related Molecular Pathways of Emphysema, Carcinoma, and Fibrosis - An Illustrative Review. Thorac Cancer Grgurevi, Hrka, Novak R, Salai G, Mitrovi, Svagu. PMID: 42639684 [PubMed - indexed for MEDLINE]
	Diverging Trajectories of Lung Cancer Burden in China, Japan, and South Korea: A Comparative Risk Assessment from the Global Burden of Disease Study 1990-2021. Thorac Cancer Zhao S, Deng G, Li D, Liang H, Tang D, Liu K. PMID: 42639674 [PubMed - indexed for MEDLINE]
	Decision-Support Framework for Nutritional Risk in Small Cell Lung Cancer: A Time-Series Model Using Imputation Strategies for Incomplete Clinical Data. Thorac Cancer Pan R, Zhao Y, Wang M, Liu W, Ji S, Liu Y, Zhang Y, Ma C, Chen M, Xu Y. PMID: 42639652 [PubMed - indexed for MEDLINE]
	PEGylated PLGA Nanoformulations For Effective Immunomodulatory Actors In Non-Small Cell Lung Cancer. Int J Nanomedicine Huang M, Zhang J, Hao Z, Wang Q, Liu W. PMID: 42639593 [PubMed - indexed for MEDLINE]
	Cordyceps sinensis and Sonodynamic Therapy in Non-Small Cell Lung Cancer: Pharmacological Basis, Therapeutic Potential, and Future Directions. Int J Nanomedicine Zhang Z, Huang C, Ling X, Gan X, Zheng Q, Zhang B, Li J, Wang L. PMID: 42639578 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor-based combinatory and alternative strategies for immune treatment of lung cancers. Front Immunol Park JY, Kwak CH, Chang YC, Kim CH. PMID: 42639301 [PubMed - indexed for MEDLINE]
	Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms. Front Oncol Leunissen D, Moonen L, van Weert T, Heijboer F, Hillen LM, Von der Thüsen J, Speel EJ, Dingemans AM, Derks JL. PMID: 42639261 [PubMed]
	Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study. Immunotargets Ther Yokouchi H, Nishihara H, Kenmotsu Y, Tsuji K, Kishikawa T, Kikuchi H, Miyauchi E, Nagano Y, Kanazawa K, Sugisaka J, Ohkuri T, Oizumi S. PMID: 42639079 [PubMed]
	Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden. Front Immunol Koulouris AV, Trontzas IP, Vathiotis IA, Livanou ME, Skribek M, Panagiotou E, Trimis A, Ekman S, Tsakonas G, Syrigos KN. PMID: 42638973 [PubMed - indexed for MEDLINE]
	Cost-Effectiveness Analysis of Ivonescimab Plus Chemotherapy versus Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer in China Based on the HARMONi-6 Trial. Risk Manag Healthc Policy Xuan F, Huang M, Yang Y, Bian H. PMID: 42638942 [PubMed]
	Quantitative stability of CT numbers in novel cone-beam CT: An intra-institution cross-scanner and longitudinal analysis. J Appl Clin Med Phys Taasti VT, Linaa MB, Byskov CS, Jensen MB, Møller DS, Hoffmann L. PMID: 42638314 [PubMed - indexed for MEDLINE]
	Diagnostic value of surveillance (18)F-FDG PET/CT for detecting recurrent non-small cell lung cancer after curative resection: a multicentre retrospective cohort study. Eur J Nucl Med Mol Imaging Hwang SH, Paeng JC, Cho A, Jeong SY, Oh SW, Park JM, Park JS, Choi JY, Kang WJ. PMID: 42637975 [PubMed - as supplied by publisher]
	Clinical-radiomic model development for local recurrence prediction in stereotactic body radiation therapy-treated lung cancer: comparative analysis with radiobiological models. Sci Rep Huang BT, Lin PX, Wang Y, Luo LM. PMID: 42637814 [PubMed - indexed for MEDLINE]
	Dose-painting after multi-block endoscopic endonasal surgery in sinonasal tumours: protocol for the SinocaRT randomised phase II trial. BMJ Open Thariat J, Clarisse B, Carsuzaa F, Lequesne J, Leconte A, Larnaudie A, Bouter J, Liem X, Humbert M, Patron V. PMID: 42637259 [PubMed - indexed for MEDLINE]
	Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial. J Thorac Oncol Wu F, Zhang W, Zhao Y, Yu Y, Fang J, Han S, Zhao M, Yao W, Wei Y, Shi J, Chen J, Li X, Hong W, Meng R, Shu Y, Zhou C, Zhou Z, Hu Y, Duan J, Yu H, Wang M, Nikolinakos PG, Le X, Han B, Zhou C. PMID: 42637134 [PubMed - as supplied by publisher]
	[80 Years of Lung Cancer - the Evolution of Diagnosis and Treatment]. Pneumologie Reinmuth N, Heigener D, Wesseler C. PMID: 42636859 [PubMed - as supplied by publisher]
	Adjuvant alectinib versus chemotherapy in resected ALK-positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial. Lancet Oncol Dziadziuszko R, Ahn JS, Barlesi F, Solomon BJ, Wu YL, Bondarenko I, Hochmair M, Horinouchi H, Lee DH, Lee JS, Planchard D, Rittmeyer A, Zhong W, Adler L, Archer V, Cardona A, Petric P, Scalori A, Ding B, Mamolo C, Smoljanovic V, Nishio M. PMID: 42636834 [PubMed - indexed for MEDLINE]
	Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. PMID: 42636833 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161508

Page 1 of 8076



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy